2016
DOI: 10.1016/j.humimm.2016.07.008
|View full text |Cite
|
Sign up to set email alerts
|

A meta-analysis of the relationship between MYO9B gene polymorphisms and susceptibility to Crohn’s disease and ulcerative colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 48 publications
0
10
0
Order By: Relevance
“…Loss-of-function mutations or overexpression of these proteins has been linked to various cancers and immune defects. Some studies support a role for MYO9b in human intestinal diseases such as inflammatory bowel disease and Crohn's disease (Li et al, 2016;Prager et al, 2014;Wang et al, 2016). The complex structure of Myo9 proteins includes a C-terminal GAP domain, which studies show attenuates RhoA activity.…”
Section: Introductionmentioning
confidence: 99%
“…Loss-of-function mutations or overexpression of these proteins has been linked to various cancers and immune defects. Some studies support a role for MYO9b in human intestinal diseases such as inflammatory bowel disease and Crohn's disease (Li et al, 2016;Prager et al, 2014;Wang et al, 2016). The complex structure of Myo9 proteins includes a C-terminal GAP domain, which studies show attenuates RhoA activity.…”
Section: Introductionmentioning
confidence: 99%
“…The Newcastle-Ottawa scale was used to evaluate the quality of studies. The scale consists of 3 aspects: selection, comparability, and exposure, with a maximum score of 9 [19]. Any disagreements were adjudicated by a third reviewer.…”
Section: Methodsmentioning
confidence: 99%
“…The quality of all included studies was evaluated independently using the Newcastle–Ottawa scale, which constituted of 3 aspects such as selection, comparability, and exposure with a maximum score of 9. [ 19 ] A total of scores of each study in ≤3, 4 to 6, ≥7 was considered as low, medium, and high-quality study, respectively. If there was discrepancy in the process of evaluation, a third investigator would adjust in the ultimate.…”
Section: Methodsmentioning
confidence: 99%